Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Comparative efficacy of novel therapies for sickle cell disease: A network meta-analysis of hydroxyurea, voxelotor, crizanlizumab, and l-glutamine

Sweta Sahu, Sravani Bhavanam, Salma Younas, Shakirat Gold-Olufadi, Henry Becerra, Kushal Kriplani, Dosbai Saparov, Ujjwal Soni, Aleksandr Markov, Konstantin Kecman

Blood (2025) 146 (Supplement 1): 6499.

https://doi.org/10.1182/blood-2025-6499

Published: 2025

Journal Articles

Mortality patterns due to aplastic anemia in the United States: A retrospective analysis from 1999 to 2023

Hakim Wazir, Amna Amjad, Dosbai Saparov, Maha Sajjad, Noora Inam, Shaheen Nawaz, Sravani Bhavanam, Konstantin Kecman, Aleksandr Markov

Blood (2025) 146 (Supplement 1): 6460.

https://doi.org/10.1182/blood-2025-6460

Published: 2025

Journal Articles

Temporal trends in cancer-associated venous thromboembolism mortality: A nationwide analysis (1999–2020)

Gaurav Sharma, Karma Patel, Dosbai Saparov, Sai Swetha Pavuluri, Victor Sebastian Arruarana, Durga prasad Gutta, Suhas Kataveni, Nidhi Lanka

Blood (2025) 146 (Supplement 1): 1352.

https://doi.org/10.1182/blood-2025-1352

Published: 2025

Journal Articles

Resolving the debate: A systematic review and network meta-analysis of hydroxyurea vs. newer FDA-approved pharmacological therapies in sickle cell disease

Rakhshanda Khan, Aneesh Sai Reddy Gurajala, Rahul Chopra, Anusha Kalluru, Sai Abhinay Reddy Narla, Dosbai Saparov, Kushal Kriplani, Nayanika Tummala, Harshawardhan Dhanraj Ramteke, Sumayya Farooqi

Blood (2025) 146 (Supplement 1): 6536.

https://doi.org/10.1182/blood-2025-6536

Published: 2025

Journal Articles

Overall survival and prognostic factors of adult patients with acute promyelocytic leukemia in the pre- all-trans-retinoic acid + arsenic trioxide (ATRA+ATO) era and the post-ATRA+ATO era in the US

Henry Becerra, Emmanuel Bugarin Estrada, Dosbai Saparov, Jose Fernandez Rengifo, Neharika Shrestha, Sravani Bhavanam, Konstantin Kecman, Karen Leiva, Nassim Said, Sundas Butt, Ayesha Fonseca-Polineni, Boris Avezbakiyev, Jen-Chin Wang

Blood (2025) 146 (Supplement 1): 8158.

https://doi.org/10.1182/blood-2025-8158

Published: 2025

Journal Articles

Sickle cell disease in the global south: Mapping the unmet burden using global burden of disease DALY estimates and its relevance to United States hematologists

Sweta Sahu, Sravani Bhavanam, Salma Younas, Shakirat Gold-Olufadi, Dosbai Saparov, Henry Becerra, Kushal Kriplani, Ujjwal Soni, Pooja Gogia Bhasin

Blood (2025) 146 (Supplement 1): 2601.

https://doi.org/10.1182/blood-2025-2601

Published: 2025

Journal Articles

Racial disparities in survival trends in burkitt lymphoma in the CAR-T cell therapy era vs pre-CAR-T cell therapy era in the United States: A population-based study

Dosbai Saparov, Henry Becerra, Azamat Abdyraimov, Neharika Shrestha, Mustafa Wasifuddin, Shakirat Gold-Olufadi, Narek Hakobyan, Philipp Barakat, Aleksandr Markov, Sravani Bhavanam, Konstantin Kecman, Victor Sebastian Arruarana, Karen Leiva, Ayesha Fonseca-Polineni, Nassim Said, Hagop Klachian, Sundas Butt, Boris Avezbakiyev, Jen-Chin Wang

Blood (2025) 146 (Supplement 1): 7185.

https://doi.org/10.1182/blood-2025-7185

Published: 2025

Journal Articles

Factors Associated with in-Hospital Mortality from Gastrointestinal Bleeding in Patients with Hemophilia

Ifeanyi Nnamdi Uche, Shakirat Gold-Olufadi, Henry Becerra, Mustafa Wasifuddin, Dosbai Saparov, Rohan Hehr, Esther Yemisi Oluwadeyi

Blood (2024) 144 (Supplement 1): 5482.

https://doi.org/10.1182/blood-2024-202657

Published: 2024

Journal Articles

Racial Disparities in in-Hospital Outcomes of Venous Thromboembolic Events in Patients with Diffuse Large B-Cell Lymphoma

Dosbai Saparov, Henry Becerra, Mustafa Wasifuddin, Ifeanyi Nnamdi Uche, Shakirat Gold-Olufadi, Azamat Abdyraimov, Narek Hakobyan, Hesham Ali Abowali, Akriti Pokhrel, Ruchi Yadav, Rukhsana Aslam, Neharika Shrestha, Aleksandr Markov, Jen Chin Wang

Blood (2024) 144 (Supplement 1): 7825.

https://doi.org/10.1182/blood-2024-211776

Published: 2024

Journal Articles

Multiple Myeloma (MM) Clinical Characteristics, Prognostic Factors and Survival in Adolescents and Young Adults (AYA)

Blood (2024) 144 (Supplement 1): 5170.7.

https://doi.org/10.1182/blood-2024-211720

Published: 2024

Journal Articles

Differences in the in-Hospital Outcomes of Sickle Cell Crisis Among Patients with and without Liver Cirrhosis: A Nationwide in-Patient Analysis

Shakirat Gold-Olufadi, Kayode Ogunniyi, Toluwalase Awoyemi, Bukky Florence Tabiti, Henry Becerra, Dosbai Saparov, Kibwey Peterkin, Ifeanyi Nnamdi Uche, Nosakhare Paul Ilerhunmwuwa, Esther Yemisi Oluwadeyi

Blood (2024) 144 (Supplement 1): 1134.

https://doi.org/10.1182/blood-2024-212127

Published: 2024

Journal Articles

Factors Associated with in-Hospital Mortality from Gastrointestinal Bleeding in Patients with Sickle Cell Disease

Ifeanyi Nnamdi Uche, Rohan Hehr, Henry Becerra, Shakirat Gold-Olufadi, Esther Yemisi Oluwadeyi, Mustafa Wasifuddin, Dosbai Saparov

Blood (2024) 144 (Supplement 1): 5324.

https://doi.org/10.1182/blood-2024-212074

Published: 2024

Journal Articles

Protein-Energy Malnutrition in Multiple Myeloma - Impact on the in-Hospital Outcomes and Thrombotic Events in Patients with Multiple Myeloma

Shakirat Gold-Olufadi, Ifeanyi Nnamdi Uche, Nosakhare Paul Ilerhunmwuwa, Kibwey Peterkin, Dosbai Saparov, Chukwuka Eneh, Stephanie Ogbonda

Blood (2024) 144 (Supplement 1): 6914.

https://doi.org/10.1182/blood-2024-201094

Published: 2024

Journal Articles

Survival Trends in Diffuse Large B-Cell Lymphoma (DLBCL) in the CAR-T Cell Therapy Era Vs Pre-CAR-T Cell Therapy Era in the United States: A Population-Based Study

Mustafa Wasifuddin, Nosakhare Paul Ilerhunmwuwa, Henry Becerra, Narek Hakobyan, Ifeanyi Nnamdi Uche, Ruchi Yadav, Akriti Pokhrel, Jin Zheng, Hesham Ali Abowali, Omid Heravi, Beka Aroshidze, Ladan Enayati, Kapilkumar Manvar, Dosbai Saparov, Siddharth Yadav, Jen-Chin Wang

Blood (2023) 142 (Supplement 1): 3765.

https://doi.org/10.1182/blood-2023-181377

Published: 2023

Update search

NARROW

Publications

Format

Article Type

Date

Availability

Comparative efficacy of novel therapies for sickle cell disease: A network meta-analysis of hydroxyurea, voxelotor, crizanlizumab, and l-glutamine

Mortality patterns due to aplastic anemia in the United States: A retrospective analysis from 1999 to 2023

Temporal trends in cancer-associated venous thromboembolism mortality: A nationwide analysis (1999–2020)

Resolving the debate: A systematic review and network meta-analysis of hydroxyurea vs. newer FDA-approved pharmacological therapies in sickle cell disease

Overall survival and prognostic factors of adult patients with acute promyelocytic leukemia in the pre- all-trans-retinoic acid + arsenic trioxide (ATRA+ATO) era and the post-ATRA+ATO era in the US

Sickle cell disease in the global south: Mapping the unmet burden using global burden of disease DALY estimates and its relevance to United States hematologists

Racial disparities in survival trends in burkitt lymphoma in the CAR-T cell therapy era vs pre-CAR-T cell therapy era in the United States: A population-based study

Factors Associated with in-Hospital Mortality from Gastrointestinal Bleeding in Patients with Hemophilia

Racial Disparities in in-Hospital Outcomes of Venous Thromboembolic Events in Patients with Diffuse Large B-Cell Lymphoma

Multiple Myeloma (MM) Clinical Characteristics, Prognostic Factors and Survival in Adolescents and Young Adults (AYA)

Differences in the in-Hospital Outcomes of Sickle Cell Crisis Among Patients with and without Liver Cirrhosis: A Nationwide in-Patient Analysis

Factors Associated with in-Hospital Mortality from Gastrointestinal Bleeding in Patients with Sickle Cell Disease

Protein-Energy Malnutrition in Multiple Myeloma - Impact on the in-Hospital Outcomes and Thrombotic Events in Patients with Multiple Myeloma

Survival Trends in Diffuse Large B-Cell Lymphoma (DLBCL) in the CAR-T Cell Therapy Era Vs Pre-CAR-T Cell Therapy Era in the United States: A Population-Based Study

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only